| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65fc9af99988f422e72154f4c526d88f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75a82a54c9af07eb5a6ee08ad70d9398
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee7f6b71973155c6c4d8a74066ea77cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b5781d80e346c4fae8ec41db17dece1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2018-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac38cb76a34a8863047d383180306b1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cf264347e942fa498c84b98e6eb3ade
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93d8090ef2613967a6a80922c4942fe1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26ce4629b479b43716338e6b453f2684 |
| publicationDate |
2019-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019006007-A1 |
| titleOfInvention |
POSOLOGICAL REGIMES FOR ANTI-TIM3 ANTIBODIES AND USES THEREOF |
| abstract |
The present invention relates to antibody molecules that bind specifically to TIM-3. The antibody molecules can be used for the treatment or prevention of cancerous or infectious conditions and disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020146196-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11708412-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021206652-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11155620-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10570204-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10752687-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10981990-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021079195-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10472419-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021051352-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021363242-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11344620-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019143607-A1 |
| priorityDate |
2017-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |